Tether, a stablecoin issuer, has made a significant investment of $200 million in Blackrock Neurotech through its venture division, Tether Evo. This move establishes Tether as the primary stakeholder in the renowned biotech firm specializing in brain-computer interface (BCI) technology. The funding will support Blackrock Neurotech in commercializing its medical tools and advancing its research and development efforts.

This investment follows Tether’s impressive net profit of $2.9 billion in the fourth quarter of 2023. Paolo Ardoino, a representative of Tether, expressed excitement about the partnership, emphasizing Blackrock Neurotech’s technology’s potential to enhance communication, rehabilitation, and cognitive functions.

Blackrock Neurotech, founded in 2008, is a pioneer in BCI technology, allowing patients with paralysis and neurological conditions to control devices using their thoughts. The company gained recognition in 2016 when Nathan Copeland used their technology to interact with former U.S. President Barack Obama.

Dr. Florian Solzbacher, co-founder of Blackrock Neurotech, views Tether’s investment as a crucial step in advancing healthcare technologies. Tether’s involvement through Tether Evo signifies its expansion beyond stablecoins, introducing divisions like Tether Data, Tether Finance, Tether Power, and Tether Education to explore the integration of technology and human potential.

Post Views: 3